References
- Aitken M, Kleinrock M, Connely N, et al. Global Oncology Trends-2023. Parsippany, NJ: IQVIA Institute; 2023.
- Ciucci A, Buttarelli M, Fagotti A, et al. Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application. Cell Mol Life Sci. 2022 Jun 16;79(7):364. doi: 10.1007/s00018-022-04395-y
- Astell KR, Sieger D. Zebrafish in vivo models of cancer and metastasis. Cold Spring Harb Perspect Med. 2020 Aug 3;10(8):a037077. doi: 10.1101/cshperspect.a037077
- Loveless R, Shay C, Teng Y. Unveiling tumor microenvironment interactions using zebrafish models. Front Mol Biosci. 2020;7:611847. doi: 10.3389/fmolb.2020.611847
- Anderson NM, Li D, Peng HL, et al. The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis. Leukemia. 2016 Jun;30(6):1365–1374. doi: 10.1038/leu.2016.26
- Letrado P, de Miguel I, Lamberto I, et al. Zebrafish: speeding up the cancer drug discovery process. Cancer Res. 2018 Nov 1;78(21):6048–6058. doi: 10.1158/0008-5472.CAN-18-1029
- Mandelbaum J, Shestopalov IA, Henderson RE, et al. Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med. 2018 Oct 1;215(10):2673–2685. doi: 10.1084/jem.20180939
- Lee HC, Lin CY, Tsai HJ. Zebrafish, an in vivo platform to screen drugs and proteins for biomedical use. Pharmaceuticals (Basel). 2021 May 24;14(6):500. doi: 10.3390/ph14060500
- Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nat Rev Drug Discov. 2021 Aug;20(8):611–628. doi: 10.1038/s41573-021-00210-8
- Ridges S, Heaton WL, Joshi D, et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012 Jun 14;119(24):5621–5631. doi: 10.1182/blood-2011-12-398818
- Gutierrez A, Pan L, Groen RW, et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J Clin Invest. 2014 Feb;124(2):644–655.
- White RM, Cech J, Ratanasirintrawoot S, et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature. 2011 Mar 24;471(7339):518–522. doi: 10.1038/nature09882
- Nakayama J, Tan L, Li Y, et al. A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis. Elife. 2021 Dec 17;10. doi: 10.7554/eLife.70151
- Wang C, Tao W, Wang Y, et al. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur Urol. 2010 Sep;58(3):418–426. doi: 10.1016/j.eururo.2010.05.024
- Zhu S, Lee JS, Guo F, et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell. 2012 Mar 20;21(3):362–373. doi: 10.1016/j.ccr.2012.02.010
- Zhang Y, Yeh JR, Mara A, et al. A chemical and genetic approach to the mode of action of fumagillin. Chem Biol. 2006 Sep;13(9):1001–1009.
- Bauer B, Mally A, Liedtke D. Zebrafish embryos and larvae as alternative animal models for toxicity testing. Int J Mol Sci. 2021 Dec 14;22(24):13417. doi: 10.3390/ijms222413417
- Sun D, Gao W, Hu H, et al. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022 Jul;12(7):3049–3062.
- Fazio M, Ablain J, Chuan Y, et al. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020 May;20(5):263–273. doi: 10.1038/s41568-020-0252-3
- Al-Hamaly MA, Turner LT, Rivera-Martinez A, et al. Zebrafish cancer avatars: a translational platform for analyzing tumor heterogeneity and predicting patient outcomes. Int J Mol Sci. 2023 Jan 24;24(3):2288. doi: 10.3390/ijms24032288
- Yan C, Brunson DC, Tang Q, et al. Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish. Cell. 2019 Jun 13;177(7):1903–1914 e14. doi: 10.1016/j.cell.2019.04.004